I. Fournier

发表

Psychometric Validation of the PROQOL-HIV Questionnaire, a New Health-Related Quality of Life Instrument–Specific to HIV Disease

O. Chassany, M. Duracinsky, C. Lalanne, 2012, Journal of acquired immune deficiency syndromes.

Prevalence of pretreatment HIV drug resistance in West African and Southeast Asian countries

V. Calvez, F. Brun-Vézinet, M. Peeters, 2018, The Journal of antimicrobial chemotherapy.

Mortality in Cambodia

A. Mounts, P. Buchy, S. Vong, 2015, Asia-Pacific journal of public health.

Late-onset neonatal sepsis: genetic differences by sex and involvement of the NOTCH pathway

Timothy H. Ciesielski, G. Sirugo, W. Scott, 2022, Pediatric Research.

Estimated glomerular filtration rate but not solute carrier polymorphisms influences anemia in HIV–hepatitis C virus coinfected patients treated with boceprevir or telaprevir-based therapy

C. Solas, B. Lacarelle, É. Bellissant, 2016, AIDS.

High efficacy of lopinavir/r-based second-line antiretroviral treatment after 24 months of follow up at ESTHER/Calmette Hospital in Phnom Penh, Cambodia

L. Ferradini, J. Delfraissy, N. Lerolle, 2011, Journal of the International AIDS Society.

Plasma and CSF pharmacokinetics of meropenem in neonates and young infants: results from the NeoMero studies

P. Clarke, M. Karlsson, S. Gupta, 2018, The Journal of antimicrobial chemotherapy.

OP-JANM180127 1908..1916

P. Clarke, M. Karlsson, S. Gupta, 2018 .

Telaprevir Enhances Ribavirin-Induced Anaemia through Renal Function Impairment

L. Cotte, J. Molina, K. Lacombe, 2015, Antiviral therapy.

Health-related quality of life and health locus of control beliefs among HIV-infected treated patients.

C. Michelet, C. Leport, B. Spire, 2005, Journal of psychosomatic research.

Interleukin-2 before antiretroviral therapy in patients with HIV infection: a randomized trial (ANRS 119).

Y. Lévy, J. Molina, I. Madelaine, 2009, The Journal of infectious diseases.

Pharmacokinetic study of raltegravir in HIV-infected patients with end-stage liver disease: the LIVERAL-ANRS 148 study.

J. Molina, D. Vittecoq, S. Haim-Boukobza, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A Treatment-Decision Score for HIV-Infected Children With Suspected Tuberculosis

C. Delacourt, G. Carcelain, S. Godreuil, 2019, Pediatrics.

The Development of PROQOL-HIV: An International Instrument to Assess the Health-Related Quality of Life of Persons Living With HIV/AIDS

Baiba Berzins, Mauro Schechter, Olivier Chassany, 2012, Journal of acquired immune deficiency syndromes.

From first-generation hepatitis C virus protease inhibitors to direct-acting antivirals: self-reported symptoms as a warning signal for potential adverse events (ANRS HC26, ANRS HC27 trials)

M. Carrieri, L. Cotte, I. Poizot-Martin, 2016, European journal of gastroenterology & hepatology.

Structured Treatment Interruptions in Primary HIV-1 Infection: The ANRS 100 PRIMSTOP Trial

C. Rouzioux, B. Hoen, F. Raffi, 2005, Journal of acquired immune deficiency syndromes.

Meropenem vs standard of care for treatment of neonatal late onset sepsis (NeoMero1): A randomised controlled trial

C. Giaquinto, F. Mosca, V. Usonis, 2018, bioRxiv.

Cost-Utility Analysis of a Dolutegravir-Based Versus Low-Dose Efavirenz-Based Regimen for the Initial Treatment of HIV-Infected Patients in Cameroon (NAMSAL ANRS 12313 Trial)

C. Charpentier, E. Delaporte, S. Eymard-Duvernay, 2020, PharmacoEconomics.

Interleukin-2 before antiretroviral therapy in patients with HIV infection: a randomized trial (ANRS 119).

Y. Lévy, J. Molina, I. Madelaine, 2009, The Journal of infectious diseases.

Pharmacokinetic study of raltegravir in HIV-infected patients with end-stage liver disease: the LIVERAL-ANRS 148 study.

J. Molina, D. Vittecoq, S. Haim-Boukobza, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.